MedTrace Logo

Assessment of TRACP-5b in Primary and Secondary Osteoporosis

NCT05103592 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2021-11-15

No results posted yet for this study

Summary

Assessment of the TRACP-5b level in 1ry OP and 2ry OP such as RA and seronegative spondylitis, that may help in surrogating the use of BMD.

Conditions

Interventions

DIAGNOSTIC_TEST

Tartrate- resistant Acid Phosphatase marker

marker could be diagnostic for osteoporosis

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • AMIRA MA MANSOUR

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-12-01
Completion
2023-05-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05103592 on ClinicalTrials.gov